MARKET INSIGHTS
Global (S)-N-Fmoc-3-Bromophenylalanine (CAS 220497-48-3) market size was valued at USD 38.2 million in 2025. The market is projected to grow from USD 40.6 million in 2026 to USD 68.4 million by 2034, exhibiting a CAGR of 6.7% during the forecast period.
(S)-N-Fmoc-3-Bromophenylalanine (CAS 220497-48-3) is a protected, non-natural amino acid derivative widely utilized in solid‑phase peptide synthesis (SPPS). The compound features a 9‑fluorenylmethoxycarbonyl (Fmoc) protecting group on the amine functionality and a bromine substituent at the meta position of the phenylalanine side chain, offering unique reactivity for further chemical modifications, including palladium‑catalyzed cross‑coupling reactions. Its high stereochemical purity in the (S)-configuration makes it particularly valuable in the development of peptide‑based pharmaceuticals, peptidomimetics, and specialty biochemical research applications.
(S)-N-Fmoc-3-Bromophenylalanine (CAS 220497-48-3) Market – View in Detailed Research Report
Top 10 Companies in the (S)-N-Fmoc-3-Bromophenylalanine Market
1. Bachem AG
Headquarters: Basel, Switzerland
Key Offering: High‑purity Fmoc‑protected amino acids and custom synthesis services for peptide research and development.
Bachem’s advanced chiral synthesis platform ensures consistent enantiomeric excess above 98% and robust analytical validation, positioning it as a trusted partner for GMP‑grade peptide production. The company has invested in scalable manufacturing to meet the growing demand for specialty building blocks in both academic and industrial settings.
Sustainability Initiatives: Implementation of green chemistry protocols in the Fmoc protection step, reducing solvent usage by 20% compared to traditional methods.
- Integrated supply chain for rapid delivery to global pharmaceutical clients.
- Dedicated R&D team for developing novel halogenated amino acid derivatives.
- Comprehensive quality documentation supporting regulatory submissions.
2. MilliporeSigma (Merck KGaA)
Headquarters: Darmstadt, Germany / Kenilworth, USA
Key Offering: Broad portfolio of Fmoc‑protected amino acids, including custom synthesis and analytical services.
Merck’s global footprint enables seamless distribution across North America, Europe, and Asia. Its focus on process optimization has led to lower cost of goods for complex halogenated residues, making it a preferred vendor for cost‑conscious research programs.
Sustainability Initiatives: Commitment to carbon neutrality in manufacturing operations by 2030, with a current reduction of 15% in greenhouse gas emissions.
- Strong partnership network with contract manufacturing organizations (CMOs).
- Investment in automated SPPS platforms to improve throughput.
- Transparent supply chain traceability for raw materials.
3. Watanabe Chemical Industries, Ltd.
Headquarters: Nagoya, Japan
Key Offering: Proprietary asymmetric synthesis of chiral amino acids and specialty Fmoc building blocks.
Watanabe’s expertise in chiral resolution and high‑yield reactions supports the production of complex halogenated residues with minimal by‑products. The company’s focus on quality control aligns with stringent regulatory requirements in the pharmaceutical sector.
Sustainability Initiatives: Adoption of renewable energy sources for all production facilities, targeting 25% renewable energy usage by 2025.
- Advanced chiral chromatography services for custom lots.
- Collaborations with academic institutions for method development.
- Robust documentation for GMP compliance.
4. AAPPTec (Advanced Automated Peptide Protein Technologies)
Headquarters: San Diego, USA
Key Offering: Automated peptide synthesis systems and custom Fmoc‑protected amino acid production.
AAPPTec’s integration of robotics and process analytics allows rapid scale‑up of specialty amino acids, reducing lead times for peptide‑based drug candidates. The company’s flexible packaging options cater to both research and industrial users.
Sustainability Initiatives: Development of solvent‑free Fmoc protection protocols to lower chemical waste.
- Custom synthesis for niche halogenated amino acids.
- Real‑time quality monitoring during synthesis.
- Partnerships with biotech firms for early‑stage development.
5. Chem‑Impex International
Headquarters: New York, USA
Key Offering: Specialty fine chemicals, including Fmoc‑protected amino acids and custom synthesis services.
Chem‑Impex leverages its extensive distribution network to deliver high‑purity reagents to global laboratories. Its focus on customer support ensures rapid resolution of technical queries.
Sustainability Initiatives: Implementation of closed‑loop solvent recovery systems, reducing solvent consumption by 30%.
- Flexible packaging sizes for laboratory and pilot‑scale needs.
- Dedicated technical support for SPPS protocols.
- Quality management system compliant with ISO 9001 and ISO 14001.
6. Shanghai Haoyuan Chemexpress Co., Ltd.
Headquarters: Shanghai, China
Key Offering: Cost‑effective Fmoc‑protected amino acids and custom synthesis for research laboratories.
Shanghai Haoyuan’s rapid manufacturing capabilities support the growing demand from CROs and academic institutions in Asia. The company maintains stringent purity standards to meet international regulatory expectations.
Sustainability Initiatives: Transition to greener reagents for the Fmoc protection step, reducing hazardous waste.
- Competitive pricing for research‑grade quantities.
- Custom synthesis of halogenated derivatives.
- Robust batch‑to‑batch consistency.
7. Nanjing Peptide Biotech Co., Ltd.
Headquarters: Nanjing, China
Key Offering: Custom synthesis of specialty amino acids, including halogenated phenylalanine derivatives.
Nanjing Peptide Biotech focuses on rapid turnaround for small‑batch orders, making it a go‑to supplier for early‑stage drug discovery projects. The company’s quality control processes align with GMP and research‑grade requirements.
Sustainability Initiatives: Adoption of low‑energy synthesis protocols, cutting energy consumption by 18%.
- Specialty amino acid portfolio tailored to peptide chemists.
- Fast delivery for time‑critical projects.
- Transparent reporting of analytical data.
8. Jiangsu Hengding Biotech Co., Ltd.
Headquarters: Nanjing, China
Key Offering: Production of Fmoc‑protected amino acids and custom synthesis for peptide therapeutics.
Jiangsu Hengding’s focus on scalable synthesis and process optimization enables the production of high‑purity halogenated residues at competitive cost. The company supports both research and industrial clients with flexible packaging options.
Sustainability Initiatives: Implementation of waste‑minimization protocols in the bromination step.
- Custom solutions for large‑scale peptide production.
- Strong emphasis on process safety.
- Comprehensive documentation for regulatory compliance.
9. Tokyo Chemical Industry Co., Ltd. (TCI)
Headquarters: Tokyo, Japan
Key Offering: Specialty fine chemicals and custom synthesis of Fmoc‑protected amino acids.
TCI’s long history in fine chemical manufacturing underpins its capability to produce complex halogenated amino acids with high purity. The company’s robust quality system supports both research and GMP applications.
Sustainability Initiatives: Reduction of hazardous solvent usage by 22% through process redesign.
- High‑purity product range for peptide synthesis.
- Custom synthesis services for niche applications.
- Global distribution network.
10. Combi-Blocks, Inc.
Headquarters: San Diego, USA
Key Offering: Specialty Fmoc‑protected amino acids and custom synthesis for peptide chemistry.
Combi‑Blocks focuses on delivering high‑quality building blocks for advanced peptide research, with an emphasis on rigorous analytical validation. The company’s agile production approach supports rapid response to emerging research needs.
Sustainability Initiatives: Development of solvent‑free reaction protocols for the Fmoc protection step.
- Custom synthesis of halogenated phenylalanine derivatives.
- Comprehensive technical support for SPPS.
- Transparent quality reporting.
Download FREE Sample Report
Get Full Report
Market Outlook
Over the forecast period, the market is expected to expand steadily, driven by the continued integration of halogenated amino acids in peptide‑based drug development. The emphasis on high‑purity, enantiomerically pure reagents and the growth of contract peptide manufacturing will support consistent demand across pharmaceutical, biotechnology, and academic sectors.
Future Trends
- Bioconjugation chemistry leveraging the aryl bromide functionality for site‑specific labeling and drug conjugates.
- AI‑assisted design of peptide libraries that incorporate non‑canonical amino acids, increasing the pace of discovery.
- Expansion of custom synthesis services to support emerging modalities such as stapled peptides and PROTACs.
- Greater focus on sustainability in the synthesis of Fmoc‑protected amino acids, including solvent‑free and renewable‑energy‑driven processes.
- Top 10 Companies in the Global Sacrificial Mold Release Agent (SMRA) Market (2026): Market Leaders Powering the Industry - October 25, 2026
- Top 10 Companies in the Global Recycled Polyester POY Market (2026): Market Leaders Driving Circular Fashion - October 25, 2026
- Top 10 Companies in the TAC Film for Display Polarizer Market (2026): Market Leaders Driving Display Innovation - October 25, 2026